Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Friday
Nov 21st
Amoxycilin + Clavulanate, tablets Print E-mail
Member of Farmavita.net is offering dossier in European CTD format for Amoxycilin + Clavulanate, 200+125 mg; 500+125 mg, tablets.

Dossier is submitted in reference member state. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.  

Amoxycilin + Clavulanate is classified as an anti-infective, according ATC index.

Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Comments
Search RSS
quisisana  - Request   |Registered |2007-03-19 17:56:38
Hello. We are a Suisse based broker and we do have a client in Switzerland who
would be interested in your dossier of amoxycilin + clavulanate. Do you have
experiences in getting the market authorization for Switzerland based on the
dossier available? What would be the downpayment price for the dossier? Do you
offer supply arrangements as well? What are the prices (FOB), especially for the
500+125mg form. Best regards
Dr. Albert Schaper
zmauko  - Amoxycilin + Clavulanate   |Administrator |2007-03-19 18:12:40
Dear Dr. Schaper

Dossier is registered in EU RMS.

We can organize
registration in Switzerland, on behalf of your client. Dossier license-out is
related of exclusive supply of bulk formulation (bulk tablets or blisters).


For quotation I need information about license-in territory (only Switzerland
or more) and forecast of sales for at least 3 years.

Please, respond to my
private e-mail.

Kind regards,

Zdravko Mauko
CEO
Farmavita.Net
Pravin Patel   |Author |2007-07-03 12:48:08
Intereste in this dossier.Please contact us
zmauko   |Administrator |2007-07-03 13:57:16
Dear Mr. Patel

Please, send me more information about you, your company and
your needs.

If you are interested in any Dossier, you should indicate
license-in territory and forecast of needs for 3 years.

Kind regards,


Zdravko Mauko
CEO
Farmavita.Net
Only registered users can write comments!

3.20 Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Related News
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network
 
< Prev   Next >
Advertisement

Featured Video

Free Hugs Campaign

Free hugs for everyone! Read more ...

Login to Farmavita.Net

membership is FREE

BabelFish Translator




Click Flag for Translation

Who's Online

We have 2 guests online

Tag Clouds

country

Joomla Modul

Farmavita.Net RSS News


Products

Click to Products

News

Click to News

Reports

Click to Reports

Events

Click to Events

CRAMS

Click to CRAMS